Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nanobiotix
5NRACurrent price
3.68 EUR
-0.02 EUR (-0.54%)
Last closed
3.91 USD
Company
www.nanobiotix.com
ISIN
US63009J1079
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
199 927 552 USD
Yield for 12 month
-30.71 %
1Y
3Y
5Y
10Y
15Y
5NRA
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.19 USDP/E ratio
–Dividend Yield
–Current Year
+32 035 726 USD
Last Year
+5 090 246 USD
Current Quarter
+4 950 094 USD
Last Quarter
+4 950 094 USD
Current Year
+32 035 726 USD
Last Year
+4 040 436 USD
Current Quarter
+4 950 094 USD
Last Quarter
+4 950 094 USD
Key Figures 5NRA
1 year
3 years
5 years
10 years
EBITDA
-22 295 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-22.02 %
PEG Ratio
–
Return On Equity TTM
-198.69 %
Wall Street Target Price
11.19 USD
Revenue TTM
42 204 000 USD
Book Value
-0.46 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
182.1 %
Dividend Yield
–
Gross Profit TTM
4 776 000 USD
Earnings per share
-0.79 USD
Diluted Eps TTM
-0.79 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-79.31 %
Dividend Analytics 5NRA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 5NRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 5NRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
48.3092
Enterprise Value Revenue
4.7009
Price Sales TTM
4.7372
Enterprise Value EBITDA
-2.447
Price Book MRQ
65.0172
Financials 5NRA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 5NRA
For 52 weeks
4.04 USD
8.96 USD
50 Day MA
4.92 USD
Shares Short Prior Month
33 298
200 Day MA
5.76 USD
Short Ratio
2.5
Shares Short
30 634
Short Percent
0.08 %
BeatStart